Tag: UDCA

Primary Biliary Cholangitis Treatment: What Works in 2026

Primary Biliary Cholangitis treatment has changed dramatically in 2026. With Ocaliva withdrawn, seladelpar and elafibranor are now the leading second-line options. Learn how UDCA, new drugs, and monitoring improve survival and quality of life.